1[1]Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys, 2000,47(3):551
2[2]Al-Hallaq HA, Zamora M, Fish BL, et al. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int J Radiat Oncol Biol Phys,2000,47(3):481
3[3]Chapman JD, Schneider RF, Urbain JL, et al. Single-photon emission computed tomography and positron-emission tomography assay for tissue oxygenation. Semin Radiat Oncol,2001,11(1): 47
4[4]Krishna MC, Subramanian S, Kuppusamy P, et al. Magnetic resonance imaging for in vivo assessment for tissue oxygen concentration. Semin Radiat Oncol, 2001,11(1):58
5[5]Alber M, Paulsen F, Eschmann SM, et al. On biologically conformal boost dose optimization. Phys Med Biol ,2003,48(2):31
6[6]Chao KSC; Bosch WR, Mutic S et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001,49(4):1171
7[7]Cha S, Knopp EA, Johnson G et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology, 2002,223(1):11
8[8]Fuss M, Wenz F, Essig M, et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys,2001,51(2):478
9[9]Haubner R,Wester HJ, Weber WA, et al. Non-invasive imaging of ανβ 3 integrin expression using a 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res,2001,61(5):1781
10[10]Anderson H, Price P. Clinical measurement of blood flow in tumours using positron emission tomography: a review. Nucl Med Comm, 2002,23(2):131
